Active pharmaceutical ingredients(APIs)can directly affect the quality of drugs,and are closely related to the safety and effectiveness of drugs.This paper reviews the legal and regulatory requirements for the current supervision of chemical APIs in China,analyzes the risk existing in the supervision of APIs in the registration inspection,drug production licensing,post-market change management and so on and puts forward regulatory proposals.
维普
万方数据